Schering AG files patent infringement lawsuit against Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc.
03-May-2005
Yasmin® is the subject of an Abbreviated New Drug Application. Barr Laboratories, Inc. is currently seeking approval from the United States Food and Drug Administration to produce and market a generic version of Yasmin®.
The patent infringement lawsuit by Schering AG and Berlex, Inc. was filed in the United States District Court for the District of New Jersey.
Most read news
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.